Jan Näslund

Title: Jan Näslund: Innovator in Alzheimer's Disease Research

Introduction

Jan Näslund is a prominent inventor based in Stockholm, Sweden. He has made significant contributions to the field of Alzheimer's disease research, holding three patents that focus on innovative treatments and preventive measures for this debilitating condition.

Latest Patents

One of his latest patents is titled "Antibodies specific for amyloid beta protofibril." This invention relates to a purified antibody or fragment that specifically binds to an Aβ protofibril. The invention also includes a composition that features such antibodies, which can be used for treating patients suspected of having Alzheimer's disease. Another notable patent is "Arctic β amyloid protofibril," which addresses the prevention and treatment of Alzheimer's disease. This invention involves the use of a non-wild type protofibril or compounds with protofibril-forming activity for active immunization aimed at treating or preventing Alzheimer's disease. It also introduces a peptide, Aβ-Arc, known for its high protofibril-forming activity, along with several applications, such as antibodies against this peptide for passive immunization against Alzheimer's disease.

Career Highlights

Throughout his career, Jan Näslund has worked with Bioarctic Neuroscience AB, where he has been instrumental in advancing research related to Alzheimer's disease. His work has been pivotal in developing innovative solutions that address the challenges posed by this condition.

Collaborations

Jan has collaborated with notable professionals in the field, including Lars Lannfelt and Camilla Nilsberth. These collaborations have further enhanced the impact of his research and inventions.

Conclusion

Jan Näslund is a key figure in the fight against Alzheimer's disease, with his patents paving the way for new treatment options. His innovative work continues to inspire advancements in medical research and therapy.